Worth reading
46Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
460
unitsWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights as stock-based compensation stock options
Who receives how much
Up to 46,000 common shares (460 stock acquisition rights, each representing 100 shares)
5 directors of the Company, excluding outside directorsUp to 46,000 shares
The lower thin line represents the existing number of shares to which these shares will be added.
The stock acquisition rights will be issued for no consideration. The exercise price is ¥1 per share.
Terms of the stock acquisition rights
Exercise price
The initial exercise price is ¥1 per share. Adjustment provisions apply in connection with share splits and consolidations, but provisions for adjustments based on the share price are Not disclosed
Exercise period
Start Date 31 May 2027 / End date 30 May 2042
Number of Stock Acquisition Rights
Total number issued Up to 460 rights / Number of unexercised units Not disclosed
Reason for acquisition without consideration
If the exercise period expires, or 5 years have elapsed from the date on which a director or audit & supervisory board member retires (in which case, the rights will lapse), If the holder commits a serious violation of laws or regulations or the Company’s internal rules, If the holder is sentenced to imprisonment or a more severe penalty, If the holder assumes or agrees to assume a position as an officer or employee of a competing company without the Company’s prior approval, If a successor to the rights dies, If the holder of the stock acquisition rights offers to waive all of the stock acquisition rights, If the Board of Directors resolves that the Company will acquire all or part of the stock acquisition rights, If an agreement for a merger in which the Company is the disappearing company, or a similar transaction, is approved at a shareholders meeting
Categories and Number of Persons Covered
Up to 460 stock acquisition rights will be allotted to 5 directors of the Company, excluding outside directors.
Intended allottee's holding policy
The holders of the stock acquisition rights and their successors may not transfer the stock acquisition rights or provide them as collateral.
Basis for determining the amount to be paid
The stock acquisition rights will be issued as directors’ compensation corresponding to their fair value for accounting purposes as of the allotment date. The specific reference share price and averaging period, discount rate or premium rate are Not disclosed
Procedures under the Corporate Code of Conduct
The decision was made at a Board of Directors meeting held on 21 May 2026. The eligible recipients are directors elected or re-elected at the shareholders meeting held on 21 May 2026. Whether opinions were obtained from independent third parties, or similar matters, is Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights as stock-based compensation stock options |
| Number of shares to be issued or disposed of | Up to 46,000 common shares (460 stock acquisition rights, each representing 100 shares) |
| Issue price and disposal price | The stock acquisition rights will be issued for no consideration. The exercise price is ¥1 per share. |
| Intended allottee | Name 5 directors of the Company, excluding outside directors / Number of Shares Up to 46,000 shares / Number of stock acquisition rights Up to 460 rights |
| Intended allottee's holding policy | The holders of the stock acquisition rights and their successors may not transfer the stock acquisition rights or provide them as collateral. |
| Basis for determining the amount to be paid | The stock acquisition rights will be issued as directors’ compensation corresponding to their fair value for accounting purposes as of the allotment date. The specific reference share price and averaging period, discount rate or premium rate are Not disclosed |
| Exercise price | The initial exercise price is ¥1 per share. Adjustment provisions apply in connection with share splits and consolidations, but provisions for adjustments based on the share price are Not disclosed |
| Exercise period | Start Date 31 May 2027 / End date 30 May 2042 |
| Number of Stock Acquisition Rights | Total number issued Up to 460 rights / Number of unexercised units Not disclosed |
| Reason for acquisition without consideration | If the exercise period expires, or 5 years have elapsed from the date on which a director or audit & supervisory board member retires (in which case, the rights will lapse), If the holder commits a serious violation of laws or regulations or the Company’s internal rules, If the holder is sentenced to imprisonment or a more severe penalty, If the holder assumes or agrees to assume a position as an officer or employee of a competing company without the Company’s prior approval, If a successor to the rights dies, If the holder of the stock acquisition rights offers to waive all of the stock acquisition rights, If the Board of Directors resolves that the Company will acquire all or part of the stock acquisition rights, If an agreement for a merger in which the Company is the disappearing company, or a similar transaction, is approved at a shareholders meeting |
| Categories and Number of Persons Covered | Up to 460 stock acquisition rights will be allotted to 5 directors of the Company, excluding outside directors. |
| Procedures under the Corporate Code of Conduct | The decision was made at a Board of Directors meeting held on 21 May 2026. The eligible recipients are directors elected or re-elected at the shareholders meeting held on 21 May 2026. Whether opinions were obtained from independent third parties, or similar matters, is Not disclosed |
Items this document does not state (16)
Total issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To strengthen the linkage between directors’ compensation and the Company’s performance and share value, and to heighten their motivation and morale to improve performance over the medium to long term and increase corporate value by sharing with shareholders not only the benefits of a rising share price but also the risks of a decline.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.